A personalized approach to obesity treatment may help breast cancer survivors improve their long-term health by identifying ...
The real promise of GLP-1 drugs goes far beyond weight loss.
Could a medicine you're already considering for weight loss also lower your risk of dementia, one of the most feared diseases ...
An experimental GLP-1 pill helped people with obesity or overweight lose as much as 12.1% of their body weight in just 36 weeks. Unlike injectable drugs such as Wegovy and Ozempic, aleniglipron is a ...
Fat loss can boost metabolism and support long-term weight management by building lean muscle. Scale changes do not show fat loss clearly because they can reflect water, digestion, or hormone changes.
The pharmaceutical company is filing lawsuits against six outlets selling versions of its promising but unapproved ...
Rafael Sepulveda Acosta, M.D. Sleep Medicine / Obesity Medicine / Internal Medicine Dr. Rafael Sepulveda Acosta is a board-certified physician with experience in internal medicine, pediatric and adult ...
Thank you for submitting your question. Keep reading Forbes Advisor for the chance to see the answer to your question in one of our upcoming stories. Our editors also may be in touch with follow-up ...
Our stories are reviewed by medical professionals to ensure you get the most accurate and useful information about your health and wellness. For more information, visit our medical review board. This ...
BURLINGTON, N.J., July 29, 2026 /PRNewswire/ -- AstaReal, Inc., the global leader for natural astaxanthin, announced new clinical findings demonstrating that AstaReal® Astaxanthin significantly ...
FDA-approved weight loss medications include Zepound, Wegovy, and Saxenda. Some drugs like Mounjaro and Ozempic are prescribed off-label for weight loss. Weight loss medications are safe, but they may ...
Chrissy Metz, who debuted her 100 lb. weight loss in May 2025, announced on Aug. 10 that she is now taking a GLP-1 Caroline Blair is a writer for PEOPLE. She has been writing about celebrities, ...